Argenx Se ADR (ARGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARGX | REGN | ALNY | ||
| Company | Argenx Se ADR | Regeneron Pharmaceuticals | Alnylam Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 741.36 | 758.40 | 319.48 | ||
| High | 766.21 | 761.91 | 322.35 | ||
| Low | 734.00 | 747.76 | 313.54 | ||
| Latest | 765.43 | 760.27 | 319.52 | ||
| Change | +17.18 | -2.77 | -10.82 | ||
| % Change | +2.30% | -0.36% | -3.28% | ||
| Volume | 361,810 | 620,087 | 1,305,104 | ||
| 20-Day Average Volume | 339,655 | 600,004 | 1,182,185 | ||
| Previous Close | 748.25 | 763.04 | 330.34 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 710.06 | 753.80 | 319.21 | ||
| 20-Day Raw Stochastic | 99.25% | 53.26% | 55.34% | ||
| 20-Day Relative Strength | 54.36 | 50.08 | 46.25 | ||
| Weighted Alpha | +24.89 | +38.60 | +9.90 | ||
| Today's Opinion | 32% Sell | 48% Buy | 72% Sell | ||
| Previous Opinion | 56% Sell | 48% Buy | 56% Sell | ||
| Last Month's Opinion | 40% Sell | 72% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.68% since 03/30/26 | +1.47% since 03/30/26 | +1.09% since 03/30/26 | ||
| Low | 708.10 on 03/31/26 | 745.00 on 04/02/26 | 313.54 on 04/07/26 | ||
| High | 766.21 on 04/07/26 | 781.21 on 04/01/26 | 335.58 on 04/06/26 | ||
| 1-Month | |||||
| %Chg | +6.64% since 03/06/26 | +0.05% since 03/06/26 | -0.36% since 03/06/26 | ||
| Low | 661.85 on 03/20/26 | 727.88 on 03/19/26 | 299.62 on 03/24/26 | ||
| High | 766.21 on 04/07/26 | 788.69 on 03/10/26 | 335.58 on 04/06/26 | ||
| 3-Month | |||||
| %Chg | -6.99% since 01/07/26 | -6.40% since 01/07/26 | -24.37% since 01/07/26 | ||
| Low | 661.85 on 03/20/26 | 718.38 on 01/20/26 | 298.00 on 02/12/26 | ||
| High | 881.89 on 01/27/26 | 821.11 on 01/09/26 | 425.19 on 01/08/26 | ||
| 6-Month | |||||
| %Chg | -4.00% since 10/07/25 | +30.35% since 10/07/25 | -30.48% since 10/07/25 | ||
| Low | 661.85 on 03/20/26 | 541.00 on 10/13/25 | 298.00 on 02/12/26 | ||
| High | 934.62 on 12/03/25 | 821.11 on 01/09/26 | 495.55 on 10/20/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 46,303,952 | 80,668,584 | 43,810,680 | ||
| Shares Outstanding, K | 61,883 | 105,720 | 132,623 | ||
| Annual Sales | 4,248,050,000 | 14,342,900,000 | 3,713,940,000 | ||
| Annual Net Income | 1,292,040,000 | 4,504,900,000 | 313,750,000 | ||
| Last Quarter Sales | 1,322,160,000 | 3,884,300,000 | 1,097,030,000 | ||
| Last Quarter Net Income | 532,950,000 | 844,600,000 | 186,420,000 | ||
| 60-Month Beta | 0.46 | 0.40 | 0.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 8.02 on 02/26/26 | 11.44 on 01/30/26 | 1.25 on 02/12/26 | ||
| Latest Earnings Date | 05/14/26 | 04/29/26 | 05/07/26 | ||
| Most Recent Dividend | N/A | 0.940 on 02/20/26 | N/A | ||
| Next Ex-Dividends Date | N/A | 02/20/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 38.24 | 21.12 | 187.56 | ||